A well-attended second meeting from the European Hematology Association (EHA) and the EHA Scientific Working on Red Cell and Iron

WhatsApp Image 2019 12 18 at 16.38.59 7

For the second time the European Hematology Association (EHA) and the EHA Scientific Working on Red Cell and Iron joined in the organization of the meeting focused on Red Cell and Iron Metabolism Defects: From basic science to clinical case application from November 7-9, 2019 in Madrid, Spain. The meeting program was chaired by Prof Achille Iolascon, Prof Clara Camaschella, Prof Maria Domenica Cappellini, Prof Dr Martina Muckenthaler, and Prof Dr Patricia Aguilar Martinez.

In line with the Topics-in-Focus (TIF) program on Hemoglobinopathies, launched by the EHA Board at EHA23, the program focused on the study of red cell and iron biology in relation to the erythropoietic differentiation process, clinical cases constructed for the different conditions while placing the emphasis on thalassemia, sickle cell disease, diserythropoietic anemias, red cell enzyme defects, atypical microcytic anemias, hereditary hemochromatosis, iron metabolism, and paroxysmal nocturnal hemoglobinuria).

The knowledge was shared through lectures and participants had the opportunity to submit an abstract or clinical case, of which a number were selected and presented throughout the meeting.

The meeting was well attended by more than 140 participants coming from a wide variety of European countries and even by delegates from Qatar, Kenia, Thailand and India amongst others. After the meeting a survey was sent to the participants, the respondents gave an overall rating of 9.3 out of  10 for the meeting.

EHA would like to thank the meeting organizers, the delegates as well as the pharmaceutical companies who supported the meeting, Agios, Bluebird Bio and Celgene.

Last Updated on Tuesday 07 January 2020.